| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Sullivan Louis W is a Director at EBS with holdings across 3 companies. Recent SEC Form 4 filings include 0 buys and 35 sells.
Estimated insider holdings value: $4.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 22, 2025 | UTHR United Therapeutics Corp | Director | Sale+OE | 5,950 | $512.13 | $3,047,200.66 | -55.0% | +1.4% | - | |
| Dec 18, 2024 | UTHR United Therapeutics Corp | Director | Sale+OE | 26,209 | $373.22 | $9,781,714.72 | -6.1% | -12.1% | +41.8% | |
| May 3, 2024 | UTHR United Therapeutics Corp | Director | Sale+OE | 5,160 | $258.39 | $1,333,284.68 | -15.1% | +24.9% | +12.3% | |
| Mar 1, 2023 | UTHR United Therapeutics Corp | Director | Sale+OE | 700 | $245.10 | $171,570.00 | -5.4% | -16.2% | -7.9% | |
| Feb 1, 2023 | UTHR United Therapeutics Corp | Director | Sale+OE | 700 | $261.33 | $182,931.00 | -5.4% | -12.0% | -16.9% | |
| Jan 3, 2023 | UTHR United Therapeutics Corp | Director | Sale+OE | 700 | $276.26 | $193,382.00 | -5.4% | -17.6% | -16.5% | |
| Dec 1, 2022 | UTHR United Therapeutics Corp | Director | Sale+OE | 700 | $279.89 | $195,923.00 | -5.4% | -11.1% | -12.7% | |
| Nov 1, 2022 | UTHR United Therapeutics Corp | Director | Sale+OE | 700 | $230.28 | $161,196.00 | -5.4% | +13.3% | -1.9% | |
| Oct 3, 2022 | UTHR United Therapeutics Corp | Director | Sale+OE | 710 | $211.56 | $150,207.60 | -5.5% | +27.8% | +3.5% | |
| Sep 2, 2022 | UTHR United Therapeutics Corp | Director | Sale+OE | 4,910 | $225.98 | $1,109,550.02 | -28.7% | +23.6% | +2.3% |